Lumos Pharma, Inc. Financial Ratios — LUMO Stock

Profitability (USD)

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-60.01	-75.86	-52.84	-59.94	-62.37	63.63	-17.96	-43.3	-40.49	-34.4	-14.22	-8.42	-26.54	-35.99	-60.27
Return on Capital (%)	- -	- -	- -	- -	- -	-111	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	74.47	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	- -	100	100	100	100	100	100	100	100	- -	100	100	100	100
EBITDA Margin (%)	-1,075.59	- -	-928.15	-1,332.01	-2,767.61	68.76	-46.73	-247.91	-248.94	-491.37	- -	-15,308.93	-13,534.78	-2,100.53	-1,783.03
Operating Margin (%)	-1,108.03	- -	-964.85	-1,378.72	-2,849.13	68.12	-49.05	-253.74	-253.84	-500.55	- -	-15,656.55	-13,629.13	-2,103.74	-1,785.18
Incremental Operating Margin (%)	- -	675.8	- -	- -	- -	86.71	- -	- -	- -	- -	-421.85	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	-966.24	-1,382.39	-2,840.81	68.16	-49.11	-253.05	-252.55	-485.51	- -	-11,688.1	-13,506.96	-2,040.38	-1,660.8
Profit Margin (%)	-1,067.88	- -	-966.19	-1,382.39	-2,852.7	55.63	-58.95	-238.08	-250.6	-429.65	- -	-3,370.83	-13,230.43	-2,039.53	-1,659.39
Net Income to Common Margin (%)	-1,067.88	- -	-966.19	-1,382.39	-2,852.7	55.63	-58.95	-238.08	-250.6	-429.65	- -	-3,370.83	-13,230.43	-2,039.53	-1,659.39
Effective Tax Rate (%)	- -	- -	- -	- -	- -	18.38	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Debt	6	7	7	1	1	1	1	1	- -	- -	- -	- -	1	- -	1
ST Debt	- -	- -	6	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	6	7	1	1	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-0.61	-0.46	-0.41	-0.06	-0.04	0.01	-0.03	-0.01	- -	- -	-0.04	-0.01	-0.02	-0.01	-0.02
Net Debt/EBITDA	0.92	0.22	1.87	0.84	1.99	-1.6	6.08	1.48	2.22	1.97	0.5	3.84	3.05	1.75	0.96
Total Debt/EBIT	-0.59	-0.44	-0.4	-0.06	-0.04	0.01	-0.03	-0.01	- -	- -	-0.04	-0.01	-0.02	-0.01	-0.02
Net Debt/EBIT	0.89	0.21	1.8	0.82	1.93	-1.61	5.79	1.44	2.17	1.93	0.5	3.75	3.02	1.75	0.96
EBITDA to Interest Expense	-1,116.22	-340.55	-413.69	-591.34	-916.67	4,564.23	-304.86	-4,030.64	-600.62	-1,178.71	-195.58	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-1,272.11	-402.94	-420.38	-626.16	-958.67	4,498.85	-342.9	-4,132.73	-600.98	-1,178.85	-195.62	- -	- -	- -	- -
EBIT to Interest Expense	-1,149.89	-354.49	-430.05	-612.08	-943.67	4,522.04	-320.02	-4,125.36	-612.45	-1,200.73	-196.32	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-207.99	-315.53	-167.99	-355.39	-192.34	-17.16	-36.64	-94.55	-131.21	-221.97	-1,079.71	-51.08	-96.04	-176.23	-397.25
Long-Term Debt/Equity (%)	- -	- -	2.56	6.57	1.77	0.48	0.19	0.22	0.07	0.04	- -	- -	0.23	- -	1.11
Long-Term Debt/Capital (%)	-16.14	-13.61	-1.27	-1.14	-0.77	-2.44	-0.47	-0.17	-0.05	-0.01	-0.32	- -	-0.21	- -	-0.19
Long-Term Debt/Total Assets (%)	26.81	35.3	1.95	4	1.46	0.41	0.17	0.16	0.06	0.03	3.46	- -	0.2	- -	0.75
Total Debt/Equity (%)	-14.99	-14.02	19.46	7.71	2.1	0.58	0.48	0.4	0.18	0.09	-0.64	0.27	0.63	0.39	2.14
Total Debt/Capital (%)	-16.24	-14	-9.66	-1.34	-0.91	-2.94	-1.19	-0.31	-0.11	-0.04	-0.64	-0.49	-0.58	-0.18	-0.36
Total Debt/Total Assets (%)	26.97	36.33	14.79	4.7	1.73	0.49	0.43	0.3	0.15	0.08	6.88	0.25	0.56	0.32	1.44
Net Debt to Equity	22.6	6.8	-88.51	-105.77	-103.05	-96.13	-99.44	-101.16	-104.54	-104.77	8.26	-84.65	-106.55	-94	-128.47
Net Debt/Capital (%)	17.43	5.65	28.65	15.36	30.7	82.68	70.86	44.22	40.06	29.33	7.64	60.07	49.75	30.58	17.9
EBITDA	-10	-16	-17	-22	-30	119	-32	-89	-71	-61	-10	-26	-31	-32	-37
EBITDA-CapEx	-11	-19	-18	-24	-32	117	-36	-91	-72	-61	-10	-26	-31	-32	-37
Operating Income (Loss)	-10	-17	-18	-23	-31	118	-34	-91	-73	-62	-10	-26	-31	-32	-37

Liquidity (USD)

API Chat

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Cash Ratio	5.31	3.93	3.94	7.45	15.88	8.11	13.33	3.47	7.2	13.65	3.92	15.27	18.48	10.04	5.13
Current Ratio	5.83	4.48	4.01	8.01	16.5	8.94	14.03	4.43	7.96	14.36	4.01	19.88	19.43	10.73	5.69
Quick Ratio	5.8	4.19	3.97	7.7	16.3	8.6	13.69	4.27	7.68	13.74	3.95	19.34	18.51	10.07	5.16
CFO/Avg Current Liab	-3.59	-4.08	-1.86	-3.01	-7.6	7.55	-1.21	-2.5	-1.61	-2.46	-1.8	-5.95	-5.12	-4.5	-4.53
Common Equity/Total Assets	-207.99	-315.53	-167.99	-355.39	-192.34	-17.16	-36.64	-94.55	-131.21	-221.97	-1,079.71	-51.08	-96.04	-176.23	-397.25
Long-Term Debt/Equity (%)	- -	- -	2.56	6.57	1.77	0.48	0.19	0.22	0.07	0.04	- -	- -	0.23	- -	1.11
Long-Term Debt/Capital (%)	-16.14	-13.61	-1.27	-1.14	-0.77	-2.44	-0.47	-0.17	-0.05	-0.01	-0.32	- -	-0.21	- -	-0.19
Long-Term Debt/Total Assets (%)	26.81	35.3	1.95	4	1.46	0.41	0.17	0.16	0.06	0.03	3.46	- -	0.2	- -	0.75
Total Debt/Equity (%)	-14.99	-14.02	19.46	7.71	2.1	0.58	0.48	0.4	0.18	0.09	-0.64	0.27	0.63	0.39	2.14
Total Debt/Capital (%)	-16.24	-14	-9.66	-1.34	-0.91	-2.94	-1.19	-0.31	-0.11	-0.04	-0.64	-0.49	-0.58	-0.18	-0.36
Total Debt/Total Assets (%)	26.97	36.33	14.79	4.7	1.73	0.49	0.43	0.3	0.15	0.08	6.88	0.25	0.56	0.32	1.44
CFO/Total Liabilities	-14.4	-18.41	-111.57	-177.98	-211.1	318.12	-105.79	-145.64	-165.69	-240.18	-13.99	-184.55	-261.56	-209.5	-233.22
CFO/CapEx	-6.51	-4.53	-46.08	-15.47	-18.63	64.16	-6.03	-29.36	-1,122.81	-5,419.86	-4,545	-766.57	-988.27	-1,267.76	- -
Altman's Z-Score	-3.55	-6.48	-0.55	6.85	24.18	22.58	27.77	2.01	3.23	-1.36	-19.28	11.4	1.81	-1.4	-6.35

Working Capital (USD)

API Chat

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Accounts Receivable Turnover	0.91	- -	3.04	2.97	0.91	64.09	15.03	2.39	1.65	2.45	- -	- -	- -	- -	- -
Days Sales Outstanding	402.52	- -	120.11	122.89	399.9	5.7	24.29	152.63	220.58	148.88	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Market Capitalization	- -	- -	43	260	556	1,107	1,040	298	254	57	94	242	58	30	26
- Cash & Cash Equivalents	15	11	39	20	61	190	196	131	159	121	5	99	95	56	35
+ Preferred Equity and Hybrid Capital	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	2	3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	6	7	7	1	1	1	1	1	- -	- -	- -	- -	1	- -	1
Enterprise Value	-8	-2	8	239	496	905	843	167	95	-64	90	144	-36	-37	-10
Total Capital	-38	-52	-74	-103	-134	-39	-79	-165	-237	-291	-59	-66	-96	-127	-161
Total Debt/Capital (%)	-16.24	-14	-9.66	-1.34	-0.91	-2.94	-1.19	-0.31	-0.11	-0.04	-0.64	-0.49	-0.58	-0.18	-0.36
Total Debt / EV	-0.79	-4.63	0.91	0.01	- -	- -	- -	- -	- -	- -	- -	- -	-0.02	-0.01	-0.06
EV/Sales	- -	- -	4.2	141.9	453.79	5.24	12.31	4.67	3.32	- -	- -	855.24	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	7.63	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	7.7	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	8.3	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	8.17	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	43	260	556	1,233	1,040	298	254	57	94	242	58	30	26
Diluted Enterprise Value	-6	1	10	241	496	1,044	846	167	95	-64	90	144	-36	-26	-9
EV per Share	- -	- -	11.68	103.68	176.61	292.55	265.53	51.84	27.44	- -	21.67	21.2	- -	- -	- -
TTM Sales	1	- -	2	2	1	173	69	36	29	12	- -	- -	- -	2	2
TTM EBITDA	-10	-16	-17	-22	-30	119	-32	-89	-71	-61	-10	-26	-31	-32	-37
TTM Operating Income	-10	-17	-18	-23	-31	118	-34	-91	-73	-62	-10	-26	-31	-32	-37
TTM Cash Flow to Firm	- -	-13	-13	-20	-26	109	-24	-66	-48	-38	-9	-23	-30	-27	-31
TTM Free Cash Flow to Firm	- -	-10	-13	-19	-24	111	-20	-64	-48	-38	-9	-23	-30	-27	-31

Multiples (USD)

API Chat

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Price/Free Cash Flow	- -	- -	-3.37	-13.57	-22.77	11.13	-51.78	-4.68	-5.26	-1.49	-10.38	-10.54	-1.95	-1.14	-0.83
EV/EBIT	- -	- -	- -	- -	- -	7.7	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-8	-2	8	239	496	905	843	167	95	-64	90	144	-36	-37	-10
Low Price	- -	- -	56.25	56.97	100.71	155.88	284.04	83.07	53.1	11.52	10.17	6.74	6.8	2.95	2.63
EV/Sales	- -	- -	4.2	141.9	453.79	5.24	12.31	4.67	3.32	- -	- -	855.24	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	7.63	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	11.52	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-2.33	-10.6	-13.32	8.26	-31.01	-5.06	-5.14	-3.16	-6.29	-17.39	-3.11	-2.14	-0.81
Price/Earnings High	- -	- -	-2.62	-16.04	-19.26	15.51	-41.58	-12.2	-10.95	-7.22	-13.83	-43.95	-9.71	-2.77	-1.09
Price/Earnings Low	- -	- -	-2.1	-5.64	-9.07	5.02	-22.34	-3.14	-2.57	-0.89	-4.34	-8.07	-1.86	-0.8	-0.63
Price/Book Value	- -	- -	-0.53	-2.48	-4.1	-27.89	-12.99	-1.8	-1.07	-0.19	-1.58	-3.67	-0.6	-0.24	-0.16
Price/Book Value Average	- -	- -	-0.52	-2.36	-3.06	-19.98	-15.64	-2.61	-1.56	-0.58	-1.02	-1.49	-0.98	-0.52	-0.17
Price/Book Value High	- -	- -	-0.58	-3.58	-4.43	-37.52	-20.97	-6.29	-3.32	-1.33	-2.25	-3.78	-3.07	-0.68	-0.23
Price/Book Value Low	- -	- -	-0.47	-1.26	-2.08	-12.15	-11.27	-1.62	-0.78	-0.16	-0.71	-0.69	-0.59	-0.19	-0.13
Price/Tangible Book Value	- -	- -	1.16	14.49	9.54	5.62	5.31	2.3	1.68	0.49	-1.59	2.08	0.65	0.51	0.95
Price/Tangible Book Value Average	- -	- -	1.15	13.78	7.12	4.03	6.4	3.33	2.44	1.47	-1.03	0.85	1.07	1.12	1.01
Price/Tangible Book Value High	- -	- -	1.29	20.86	10.3	7.56	8.58	8.03	5.2	3.36	-2.26	2.14	3.32	1.44	1.36
Price/Tangible Book Value Low	- -	- -	1.03	7.34	4.85	2.45	4.61	2.07	1.22	0.41	-0.71	0.39	0.64	0.41	0.78
Price/Sales	- -	- -	22.81	153.97	508.97	6.41	15.19	8.33	8.84	4.53	- -	1,440.71	251.12	19.85	12.63
Price/Sales Average	- -	- -	22.55	146.47	379.95	4.59	18.28	12.06	12.89	13.57	- -	586.33	412.03	43.67	13.45
Price/Sales High	- -	- -	25.3	221.71	549.44	8.63	24.51	29.05	27.44	31.04	- -	1,481.46	1,284.6	56.47	18.07
Price/Sales Low	- -	- -	20.25	77.97	258.76	2.79	13.17	7.48	6.43	3.82	- -	271.92	246.41	16.22	10.44
Price/Cash Flow	- -	- -	-3.3	-12.69	-21.55	10.15	-43.19	-4.52	-5.26	-1.49	-10.38	-10.52	-1.95	-1.14	-0.83
Price/Cash Flow Average	- -	- -	-3.26	-12.07	-16.08	7.27	-51.99	-6.54	-7.66	-4.46	-6.72	-4.28	-3.2	-2.5	-0.89
Price/Cash Flow High	- -	- -	-3.66	-18.27	-23.26	13.65	-69.7	-15.76	-16.32	-10.2	-14.77	-10.82	-9.97	-3.23	-1.19
Price/Cash Flow Low	- -	- -	-2.93	-6.43	-10.95	4.42	-37.46	-4.06	-3.83	-1.25	-4.64	-1.99	-1.91	-0.93	-0.69
Price/Free Cash Flow Average	- -	- -	-3.33	-12.9	-17	7.98	-62.33	-6.77	-7.67	-4.46	-6.72	-4.29	-3.2	-2.5	-0.89
Price/Free Cash Flow High	- -	- -	-3.74	-19.53	-24.58	14.98	-83.56	-16.31	-16.33	-10.21	-14.77	-10.84	-9.98	-3.23	-1.19
Price/Free Cash Flow Low	- -	- -	-2.99	-6.87	-11.58	4.85	-44.9	-4.2	-3.83	-1.26	-4.64	-1.99	-1.91	-0.93	-0.69
EV/Sales Average	- -	- -	5.28	135.28	324.99	3.5	15.44	8.4	7.37	3.9	- -	0.86	2.23	7.05	- -
EV/Sales High	- -	- -	8.03	210.53	494.48	7.53	21.67	25.39	21.93	21.37	- -	895.99	874.81	19.85	1.25
EV/Sales Low	- -	- -	2.98	66.78	203.81	1.7	10.33	3.82	0.91	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	0.57	-0.04	-0.57	-10.16	-11.74	5.08	-33.04	-3.39	-2.96	-0.79	-5.78	-0.01	-0.02	-0.34	0.19
EV/EBITDA High	0.57	-0.04	-0.87	-15.81	-17.87	10.95	-46.37	-10.24	-8.81	-4.35	-13.26	-5.85	-6.46	-0.94	-0.07
EV/EBITDA Low	0.57	-0.04	-0.32	-5.01	-7.36	2.47	-22.1	-1.54	-0.37	1.19	-3.84	2.05	1.21	0.97	0.36
EV/EBIT Average	0.55	-0.04	-0.55	-9.81	-11.41	5.13	-31.48	-3.31	-2.9	-0.78	-5.75	-0.01	-0.02	-0.33	0.19
EV/EBIT High	0.55	-0.04	-0.83	-15.27	-17.36	11.05	-44.17	-10.01	-8.64	-4.27	-13.21	-5.72	-6.42	-0.94	-0.07
EV/EBIT Low	0.55	-0.04	-0.31	-4.84	-7.15	2.49	-21.06	-1.5	-0.36	1.17	-3.83	2	1.2	0.97	0.36
Last Price	- -	- -	63.36	112.5	198.09	357.75	327.51	92.52	72.99	13.68	22.77	35.71	6.93	3.61	3.18
High Price	- -	- -	70.29	162	213.84	481.32	528.57	322.74	226.53	93.69	32.4	36.72	35.45	10.27	4.55
Enterprise Value Average	-6	1	10	228	355	603	1,058	300	212	49	56	- -	1	11	-7
Enterprise Value High	-6	1	15	355	540	1,300	1,484	908	629	267	130	151	201	30	3
Enterprise Value Low	-6	1	6	113	223	293	708	137	26	-73	38	-53	-38	-31	-13

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Shares Outstanding	2	2	2	2	3	3	3	3	4	4	4	8	8	8	8
Diluted Weighted Avg Shares	2	2	1	2	3	3	3	3	3	4	4	7	8	8	8
Basic Weighted Avg Shares	2	2	1	2	3	3	3	3	3	4	4	7	8	8	8
Revenue per Share	0.58	- -	2.78	0.73	0.39	55.8	21.57	11.11	8.25	3.02	- -	0.02	0.03	0.18	0.25
EBITDA per Share	-6.29	-10.02	-25.79	-9.73	-10.77	38.36	-10.08	-27.54	-20.55	-14.83	-2.36	-3.79	-3.74	-3.82	-4.49
Operating Income per Share	-6.48	-10.43	-26.8	-10.07	-11.09	38.01	-10.58	-28.19	-20.95	-15.11	-2.37	-3.88	-3.76	-3.83	-4.5
Basic EPS, GAAP	-6.24	-10.15	-26.84	-10.1	-11.1	31.04	-12.71	-26.45	-20.69	-12.97	-2.34	-0.84	-3.65	-3.71	-4.18
Basic EPS from Cont Ops	-6.39	-10.37	-26.84	-10.1	-11.1	31.04	-12.71	-26.45	-20.69	-12.97	-2.34	-0.84	-3.65	-3.71	-4.18
Diluted EPS, GAAP	-6.24	-10.15	-26.84	-10.1	-11.1	27.85	-12.71	-26.45	-20.69	-12.97	-2.34	-0.84	-3.65	-3.71	-4.18
Diluted EPS from Cont Ops	-6.39	-10.37	-26.84	-10.1	-11.1	27.85	-12.71	-26.45	-20.69	-12.97	-2.34	-0.84	-3.65	-3.71	-4.18
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-5.72	-8.31	-19.22	-8.87	-9.19	35.26	-7.58	-20.48	-13.88	-9.18	-2.19	-3.39	-3.56	-3.18	-3.82
Free Cash Flow per Basic Share	-6.6	-10.14	-19.63	-9.44	-9.69	34.71	-8.84	-21.18	-13.89	-9.18	-2.19	-3.4	-3.56	-3.18	-3.82
Cash & Equivalents per Share	10.77	8.04	62.3	9.42	21.91	65.56	62.27	40.84	45.63	29.22	1.2	14.56	11.38	8.04	4.43
Book Value per Share	-29.52	-39.66	-120.61	-45.3	-48.32	-12.83	-25.21	-51.31	-68.16	-70.33	-14.4	-9.72	-11.56	-15.21	-19.82
Tangible Book Value per Share	-26.18	-33.21	54.57	7.76	20.77	63.67	61.64	40.21	43.57	27.86	-14.35	17.2	10.68	7.12	3.35

Lumos Pharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)